Cajeta, Helen .

HRN: 05-19-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
CEFUROXIME 1.5GM (VIAL)
03/17/2025
03/18/2025
IV
1.5
PTOR
For Completion Curretage
Waiting Final Action 
05/18/2026
CEFUROXIME 500MG (TAB)
05/18/2026
05/25/2026
ORAL
500mg
BID
S/P NSVD With RMLE And Repair; PID
Checking Initial Appropriateness 
05/18/2026
METRONIDAZOLE 500MG (TAB)
05/18/2026
05/25/2026
ORAL
500mg
TID
S/P NSVD With RMLE And Repair; PID
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: